[English] 日本語
Yorodumi- PDB-9cca: Cryo-EM structure of a designed pyridoxal phosphate (PLP) synthas... -
+
Open data
-
Basic information
| Entry | Database: PDB / ID: 9cca | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Title | Cryo-EM structure of a designed pyridoxal phosphate (PLP) synthase fused to a designed circumsporozoite protein antigen from Plasmodium falciparum (CSP-P1-CSP and CSP-P2-CSP) | ||||||||||||||||||||||||
Components |
| ||||||||||||||||||||||||
Keywords | BIOSYNTHETIC PROTEIN / synthase / complex | ||||||||||||||||||||||||
| Function / homology | Function and homology informationvitamin B6 biosynthetic process / amine-lyase activity / pyridoxine metabolic process / glutaminase complex / pyridoxal 5'-phosphate synthase (glutamine hydrolysing) / pyridoxal 5'-phosphate synthase (glutamine hydrolysing) activity / response to singlet oxygen / pyridoxal phosphate biosynthetic process / pyridoxine biosynthetic process / host cell surface binding ...vitamin B6 biosynthetic process / amine-lyase activity / pyridoxine metabolic process / glutaminase complex / pyridoxal 5'-phosphate synthase (glutamine hydrolysing) / pyridoxal 5'-phosphate synthase (glutamine hydrolysing) activity / response to singlet oxygen / pyridoxal phosphate biosynthetic process / pyridoxine biosynthetic process / host cell surface binding / glutaminase / symbiont entry into host / entry into host cell by a symbiont-containing vacuole / glutaminase activity / heparan sulfate proteoglycan binding / amino acid metabolic process / catalytic activity / side of membrane / cell surface / identical protein binding / plasma membrane / cytosol / cytoplasm Similarity search - Function | ||||||||||||||||||||||||
| Biological species | ![]() | ||||||||||||||||||||||||
| Method | ELECTRON MICROSCOPY / single particle reconstruction / cryo EM / Resolution: 2.95 Å | ||||||||||||||||||||||||
Authors | Shi, D. / Ma, R. / Tang, W.K. / Tolia, N.H. | ||||||||||||||||||||||||
| Funding support | United States, 1items
| ||||||||||||||||||||||||
Citation | Journal: Nat Microbiol / Year: 2025Title: A Plasmodium-derived nanoparticle vaccine elicits sterile protection against malaria in mice. Authors: Dashuang Shi / Rui Ma / Richi Gupta / Thayne H Dickey / Palak N Patel / Nichole D Salinas / Wai Kwan Tang / Alaysies Queen / Myesha Singleton / Nida Delbe / Solomon Conteh / Lynn E Lambert / ...Authors: Dashuang Shi / Rui Ma / Richi Gupta / Thayne H Dickey / Palak N Patel / Nichole D Salinas / Wai Kwan Tang / Alaysies Queen / Myesha Singleton / Nida Delbe / Solomon Conteh / Lynn E Lambert / Patrick E Duffy / Niraj H Tolia / ![]() Abstract: Protein nanoparticles in infectious disease vaccines enable protection through the periodic arrangement of antigens on their surface. These nanoparticles arise from organisms unrelated to the target ...Protein nanoparticles in infectious disease vaccines enable protection through the periodic arrangement of antigens on their surface. These nanoparticles arise from organisms unrelated to the target disease, limiting their role as presentation platforms. Nanoparticles may also be compromised by pre-existing immunity to the nanoparticle carrier and may induce autoimmunity if conserved epitopes exist. Here we developed a potent multivalent malaria vaccine using an engineered Plasmodium falciparum pyridoxal 5'-phosphate (PLP) synthase as a nanoparticle that presents a designed P. falciparum circumsporozoite protein (CSP) and the Plasmodium vivax cell-transversal protein for ookinetes and sporozoites (CelTOS). These engineered vaccines elicited high titres of anti-CSP and anti-CelTOS antibodies, and three doses provided complete sterile protection against malaria in a mouse model. Cryogenic electron microscopy resolved a 2.95-Å resolution structure of the PLP nanoparticle including amino acid changes engineered to stabilize the nanoparticle. PLP synthase has no identifiable human ortholog limiting its propensity for autoimmunity or pre-existing immunity, and the engineered nanoparticles possess desirable manufacturing characteristics. These studies established an effective nanoparticle platform for malaria and infectious disease vaccines. | ||||||||||||||||||||||||
| History |
|
-
Structure visualization
| Structure viewer | Molecule: Molmil Jmol/JSmol |
|---|
-
Downloads & links
-
Download
| PDBx/mmCIF format | 9cca.cif.gz | 2.4 MB | Display | PDBx/mmCIF format |
|---|---|---|---|---|
| PDB format | pdb9cca.ent.gz | 1.6 MB | Display | PDB format |
| PDBx/mmJSON format | 9cca.json.gz | Tree view | PDBx/mmJSON format | |
| Others | Other downloads |
-Validation report
| Summary document | 9cca_validation.pdf.gz | 1.6 MB | Display | wwPDB validaton report |
|---|---|---|---|---|
| Full document | 9cca_full_validation.pdf.gz | 1.6 MB | Display | |
| Data in XML | 9cca_validation.xml.gz | 133.2 KB | Display | |
| Data in CIF | 9cca_validation.cif.gz | 203.2 KB | Display | |
| Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/cc/9cca ftp://data.pdbj.org/pub/pdb/validation_reports/cc/9cca | HTTPS FTP |
-Related structure data
| Related structure data | ![]() 45440MC M: map data used to model this data C: citing same article ( |
|---|---|
| Similar structure data | Similarity search - Function & homology F&H Search |
-
Links
-
Assembly
| Deposited unit | ![]()
|
|---|---|
| 1 |
|
-
Components
| #1: Protein | Mass: 58417.055 Da / Num. of mol.: 12 Mutation: K198R,K289C,S293C in Pdx1 (Uniprot numbering: K83R,K174C,S178C) Source method: isolated from a genetically manipulated source Details: Pdx1 between duplicated portions of CSP (residues 101 to 114, 131 to 150, 310 to 383), so that it is CSP-Pdx1-CSP Source: (gene. exp.) ![]() Gene: CSP, PF3D7_0304600, pdx1, PFF1025c / Production host: ![]() References: UniProt: Q7K740, UniProt: C6KT50, pyridoxal 5'-phosphate synthase (glutamine hydrolysing) #2: Protein | Mass: 49843.617 Da / Num. of mol.: 12 Mutation: N179Q,N242Q,H310N in Pdx2 (Uniprot numbering: N65Q,N128Q,H196N) Source method: isolated from a genetically manipulated source Details: Pdx2 between duplicated portions of CSP (residues 101 to 114, 131 to 150, 310 to 383), so that it is CSP-Pdx2-CSP Source: (gene. exp.) ![]() Gene: CSP, PF3D7_0304600, PDX2, PF11_0169, PF3D7_1116200 / Production host: ![]() References: UniProt: Q7K740, UniProt: Q8IIK4, pyridoxal 5'-phosphate synthase (glutamine hydrolysing), glutaminase Has protein modification | Y | |
|---|
-Experimental details
-Experiment
| Experiment | Method: ELECTRON MICROSCOPY |
|---|---|
| EM experiment | Aggregation state: PARTICLE / 3D reconstruction method: single particle reconstruction |
-
Sample preparation
| Component |
| ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular weight | Experimental value: NO | ||||||||||||||||||||||||
| Source (natural) |
| ||||||||||||||||||||||||
| Source (recombinant) |
| ||||||||||||||||||||||||
| Buffer solution | pH: 7.4 | ||||||||||||||||||||||||
| Specimen | Embedding applied: NO / Shadowing applied: NO / Staining applied: NO / Vitrification applied: YES | ||||||||||||||||||||||||
| Vitrification | Cryogen name: ETHANE |
-
Electron microscopy imaging
| Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
|---|---|
| Microscopy | Model: TFS KRIOS |
| Electron gun | Electron source: FIELD EMISSION GUN / Accelerating voltage: 300 kV / Illumination mode: SPOT SCAN |
| Electron lens | Mode: BRIGHT FIELD / Nominal defocus max: 2000 nm / Nominal defocus min: 700 nm |
| Image recording | Electron dose: 53.8 e/Å2 / Film or detector model: GATAN K3 (6k x 4k) |
-
Processing
| EM software | Name: PHENIX / Version: 1.21.1_5286 / Category: model refinement | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CTF correction | Type: NONE | ||||||||||||||||||||||||
| 3D reconstruction | Resolution: 2.95 Å / Resolution method: FSC 0.143 CUT-OFF / Num. of particles: 251050 / Symmetry type: POINT | ||||||||||||||||||||||||
| Atomic model building | Protocol: FLEXIBLE FIT / Space: REAL / Target criteria: Cross-correlation coeffcient | ||||||||||||||||||||||||
| Atomic model building |
| ||||||||||||||||||||||||
| Refinement | Cross valid method: NONE Stereochemistry target values: GeoStd + Monomer Library + CDL v1.2 | ||||||||||||||||||||||||
| Displacement parameters | Biso mean: 61.01 Å2 | ||||||||||||||||||||||||
| Refine LS restraints |
|
Movie
Controller
About Yorodumi





United States, 1items
Citation
PDBj





FIELD EMISSION GUN

